The administration of a single dose of whole-plant cannabis via a thermal-metered inhaler is effective and well tolerated among patients suffering from neuropathy (nerve pain), according to clinical trial data published online ahead of print in the Journal of Pain and Palliative Care Pharmacotherapy.
Medical Cannabis News & Information
A new study being published in the upcoming issue of the journal BMC Musculoskeletal Disorders, and e-published ahead of print by the National Institute of health, has found that a cannabinoid receptor agonist can successfully help against some of the primary symptoms of rheumatoid arthritis (RA), indicating that cannabis, which is a natural agonist to the body’s cannabinoid receptors, may provide a treatment option for the condition.
A study published this month in the journal Neuropharmacology, and published online by the U.S. National Institute of Health, has found that prolonged administration of a compound meant to mimic the effects of cannabis can improve motor symptoms and stimulate neuroprotective processes in those with Huntington’s disease.
A study published this month by the Journal of Alzheimher’s Disease has found that both THC (tetrahydrocannabinol) and CBD (cannabidiol) may provide a viable treatment option for Alzheimer’s Disease, and combining the cannabis compounds is even more effective.
Washington, D.C.: NORML has updated its homepage's medical cannabis section, including a newly designed national map of medical marijuana states to reflect the recent surge in states that have passed so-called 'CBD-only' legislation.
Currently in the United States, 35 states have reformed their laws via legislation or binding voter ballot initiative to allow qualified patients medical access to cannabis products. This time last year, 21 states and the District of Columbia had medical cannabis laws on the books--a sixty percent increase in a single year.